Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
Catalin O Codreanu,1 Nemanja Damjanov2 1Rheumatology Department, Center of Rheumatic Diseases, Bucharest, Romania; 2Institute of Rheumatology, School of Medicine, University of Belgrade, Belgrade, SerbiaAbstract: Over the past decade, the use of biologics has significantly changed the management of...
Guardado en:
Autores principales: | Codreanu C, Damjanov N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/748d502621814fdc9fac5569ae97662a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert J, et al.
Publicado: (2015) -
Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Alfredomaria Lurati, et al.
Publicado: (2009) -
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021) -
Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021) -
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
por: Nobunori Takahashi, et al.
Publicado: (2020)